Brett Garrison

Brett is a patent litigator focused on Hatch-Waxman and ANDA litigation, with significant experience representing generic pharmaceutical companies in high-stakes district court proceedings. He has played key roles in multiple Hatch-Waxman trials and has secured wins at both the trial and appellate levels. Brett regularly handles matters involving complex, multi-patent disputes across a range of drug products, from inhalation therapies to ophthalmic and injectable formulations. His experience spans all phases of litigation, including early case strategy, dispositive motion practice, and trial. He has achieved favorable outcomes through both litigation and settlement, including dismissals following strong merits positions and post-trial resolutions. Brett’s background in chemistry further strengthens his ability to work effectively with scientific experts and develop persuasive technical arguments.